Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

49.32
+1.813.81%
Volume:751.13K
Turnover:36.40M
Market Cap:7.80B
PE:50.34
High:49.41
Open:48.29
Low:47.97
Close:47.51
Loading ...

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

Top Research Reports for Exxon Mobil, Bristol-Myers Squibb & Chubb

Zacks
·
03 Apr

Evercore ISI Adjusts Bio-Techne Price Target to $70 From $75, Maintains Outperform Rating

MT Newswires Live
·
02 Apr

BRIEF-Leica Biosystems And Bio-Techne Expand Partnership To Enable Protease-Free Workflows For Automated Spatial Multiomics On The BOND RX Research Staining Instrument

Reuters
·
02 Apr

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the Bond Rx Research Staining Instrument

THOMSON REUTERS
·
02 Apr

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

PR Newswire
·
02 Apr

Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Apr

RBC Trims Price Target on Bio-Techne to $79 From $80, Maintains Sector Perform Rating

MT Newswires Live
·
01 Apr

Bio-Techne Opens New Customer Experience Centre in Germany

Zacks
·
31 Mar

Bio-Techne Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
29 Mar

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

StockStory
·
28 Mar

Bio-Techne to Open New Customer Facility in Germany

MT Newswires Live
·
26 Mar

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany

PR Newswire
·
26 Mar

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
26 Mar

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting

PR Newswire
·
24 Mar

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
20 Mar

Bio-Techne Initiated at Outperform by Evercore ISI Group

Dow Jones
·
18 Mar

Evercore ISI Initiates Bio-Techne at Outperform With $75 Price Target

MT Newswires Live
·
18 Mar

Bio-Techne initiated with an Outperform at Evercore ISI

TIPRANKS
·
18 Mar

Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future

TIPRANKS
·
18 Mar